CytomX Therapeutics Inc. (CTMX) at a glance

CytomX Therapeutics Inc. (CTMX) is a small-cap Healthcare company. It trades at $3.27, with a P/E of 15.9, a -166.4% profit margin and revenue decline of 79.9%. It does not pay a dividend. Vestovix scores it 35/100 overall. Its strongest dimension is Value (65/100) and its weakest is Growth (11/100). It carries above-market volatility, so expect larger swings.

Price

$3.27

Market cap

$655.3M

P/E ratio

15.9

Dividend yield

None

Beta

2.09

52-week range

$1.90 to $8.21